Choline

Choline

SCHEMBL933567

C[N+](C)(C)CCO.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
CYP3A4 P08684 1/20 0.46
SLC5A7 Q9GZV3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL924745 0.82 BBOX1 (0.30)
SCHEMBL29388164 0.82 BBOX1 (0.30)
Trifluoromethanesulfonic Acid SCHEMBL28047635 0.81 MEN1 (0.52) MEN1LMNAKMT2ACYP3A4SLC5A7
Trifluoromethanesulfonic Acid SCHEMBL3785097 0.79 MEN1 (0.50) MEN1LMNAKMT2ACYP3A4SLC5A7
Trifluoromethanesulfonamide SCHEMBL28047774 0.79 LMNA (0.50) MEN1LMNAKMT2ACYP3A4SLC5A7
Trifluoromethanesulfonic Acid SCHEMBL29160398 0.79 CYP3A4 (0.56) MEN1LMNAKMT2ACYP3A4SLC5A7
Trifluoromethanesulfonamide SCHEMBL28047636 0.79 LMNA (0.50) MEN1LMNAKMT2ACYP3A4SLC5A7
SCHEMBL31375747 0.79 PSMD14 (0.37)
SCHEMBL925224 0.78 DNM1 (0.41) MEN1LMNAKMT2A
Tetramethylammonium Ion SCHEMBL2940600 0.78 CA1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4515024-A1 METHOD FOR PRODUCING AN IRON NITRIDE COATING ON THE SURFACE OF AN IRON OR IRON ALLOY SUBSTRATE Brembo S.p.A. (IT) 2025-03-05 EP claimed
WO-2023209585-A1 METHOD FOR PRODUCING AN IRON NITRIDE COATING ON THE SURFACE OF AN IRON OR IRON ALLOY SUBSTRATE BREMBO S.P.A. (IT) 2023-11-02 WO claimed
CN-111435705-B Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2023-04-07 CN claimed
CN-114570219-A Pollution-resistant separation membrane with ionic liquid layer on surface and preparation method thereof 浙江大学 2022-06-03 CN claimed
US-8772438-B2 Preparation of polyamides Invista North America S.är.l. (US) 2014-07-08 US claimed
US-20120264907-A1 PREPARATION OF POLYAMIDES INVISTA NORTH AMERICA S.A.R.L. (US) 2012-10-18 US claimed
EP-2451863-A1 PREPARATION OF POLYAMIDES Invista Technologies S.A R.L. (CH) 2012-05-16 EP claimed
WO-2011004138-A1 PREPARATION OF POLYAMIDES INVISTA TECHNOLOGIES S.A.R.L. (CH) 2011-01-13 WO claimed
US-7442841-B2 Extraction process INVISTA NORTH AMERICA S.A R.L. (US) 2008-10-28 US claimed
US-20080051609-A1 EXTRACTION PROCESS INVISTA NORTH AMERICA S.A.R.L. (US) 2008-02-28 US claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
WO-2025128460-A1 ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF WILLIAMS RICHARD KENT (US) 2025-06-19 WO disclosed
EP-4515024-A1 METHOD FOR PRODUCING AN IRON NITRIDE COATING ON THE SURFACE OF AN IRON OR IRON ALLOY SUBSTRATE Brembo S.p.A. (IT) 2025-03-05 EP disclosed
WO-2023209585-A1 METHOD FOR PRODUCING AN IRON NITRIDE COATING ON THE SURFACE OF AN IRON OR IRON ALLOY SUBSTRATE BREMBO S.P.A. (IT) 2023-11-02 WO disclosed
CN-114380699-B Method for synthesizing isophorone diamine, catalyst and preparation method thereof 山东新和成维生素有限公司 2023-07-04 CN disclosed
WO-2011004138-A1 PREPARATION OF POLYAMIDES INVISTA TECHNOLOGIES S.A.R.L. (CH) 2011-01-13 WO disclosed
EP-2051788-A1 EXTRACTION PROCESS USING AN IONIC LIQUID Invista Technologies S.à.r.l. (CH) 2009-04-29 EP disclosed
US-7442841-B2 Extraction process INVISTA NORTH AMERICA S.A R.L. (US) 2008-10-28 US disclosed
US-20080051609-A1 EXTRACTION PROCESS INVISTA NORTH AMERICA S.A.R.L. (US) 2008-02-28 US disclosed
WO-2008022233-A1 EXTRACTION PROCESS USING AN IONIC LIQUID INVISTA TECHNOLOGIES S.A.R.L. (CH) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051609-A1 EXTRACTION PROCESS ADH1C, ADH1A, ADH5 MEN1 3505/4885LMNA 971/4885KMT2A 2389/4885
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof MYOC, MB, MYOF MEN1 1273/4885LMNA 32/4885KMT2A 4530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.